Anti-Mullerian hormone levels in breast cancer patients receiving chemotherapy with or without concurrent luteinizing hormone-releasing hormone agonist: results from the PROMISE phase III trial

C. Marrocco,B. Conte, G. Rossi, C. Pirrone, D. Favero, C. Massarotti, P. Anserini, P. Fregatti, B. Cardinali, G. Buzzati,A. Levaggi,F. Poggio, E. Blondeaux,L. Del Mastro,M. Lambertini

HUMAN REPRODUCTION(2022)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要